August Group Capital Ltd

Position in ABBV — AbbVie Inc.

CIK 2107394 Toronto, A6

Position in ABBV

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$870,926

+$97,315 QoQ

Shares Held

3,461

-2.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.50%

of 13F equity value

Holder Rank

#2,674

of 4,153 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

August Group Capital Ltd holds $3,612,237 across 6 Drug Manufacturers - General names. ABBV ranks #2 (24.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	822	$985,931
2	ABBV	AbbVie Inc. This page	3,461	$870,926
3	JNJ	Johnson & Johnson	2,878	$730,925
4	MRK	Merck & Co., Inc.	3,033	$389,740
5	AZN	Astrazeneca PLC	1,753	$332,403
6	NVS	Novartis AG	1,929	$302,312

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$870,926	3,461	-2.7%	Shares	Sole	2026-08-11
2026-03-31	$773,611	3,557	-10.2%	Shares	Sole	2026-05-14
2025-12-31	$905,048	3,961	—	Shares	Sole	2026-02-12
No filing history on record for this holder in this stock.